SAN JOSE, Calif.--(BUSINESS WIRE)--Micrus Endovascular Corporation (NASDAQ: MEND) today announced that John Kilcoyne, Chairman and CEO, will present at the 7th Annual Needham & Company, LLC Biotechnology & Medical Technology Conference on Wednesday, June 11 at 10:30 a.m. Eastern time (7:30 a.m. Pacific time).
